Team Category: Leadership Team

Mr. Frohlich is the Chief Executive Officer and a member of the Jade Biosciences Board of Directors. From June 2021 to October 2023, Mr. Frohlich served as Chief Operating Officer and, from January 2019 to June 2021, as Chief Business Officer at Chinook Therapeutics, Inc., a Nasdaq-listed biopharmaceutical company that was acquired by Novartis AG … Continued

Dr. King is Jade Biosciences’ Chief Scientific Officer & Head of Research and Development. Prior to his involvement in founding Jade, Dr. King served as Chief Scientific Officer at Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company that was acquired by Novartis AG, where he was responsible for overseeing the discovery research, non-clinical development, translational … Continued

Edward R. Conner, M.D., is the Chief Medical Officer of Jade Biosciences. He brings more than 20 years of experience in clinical development, translational medicine and regulatory strategy, with deep expertise in immunology and the advancement of mechanism-based therapies across early- to late-stage programs.  Prior to joining Jade, Dr. Conner served as Chief Medical Officer of Ardelyx, Inc. Prior to Ardelyx, … Continued

Brad Dahms is the Chief Financial Officer of Jade Biosciences. He brings over 15 years of financial and strategic leadership experience across the biotechnology and investment banking sectors, with a focus on corporate finance, capital markets, and business development. Prior to joining Jade, Mr. Dahms was Chief Financial Officer and Chief Business Officer of IDRx, … Continued

Elizabeth Balta is the Chief Legal Officer and Corporate Secretary of Jade Biosciences. She most recently served as General Counsel of Icosavax, where she led all aspects of the company’s legal affairs from September 2021 until the acquisition of Icosavax by AstraZeneca in February 2024. Prior to joining Icosavax, Ms. Balta served as Associate General … Continued

Mr. Quick is the Senior Vice President of Finance at Jade Biosciences, bringing over 15 years of financial leadership in the biotechnology and pharmaceutical sectors. At Jade, he oversees the company’s finance, accounting, and treasury functions. Prior to joining Jade, he led financial operations at Myeloid Therapeutics, managing key areas such as accounting and treasury. … Continued

Valerie Fauvelle is the Senior Vice President of Regulatory & Quality at Jade Biosciences. She brings nearly 25 years of experience in the biotech and pharma industries where she developed expertise in regulatory submissions, compliance frameworks, and quality oversight. Prior to joining Jade, she held leadership roles at several companies, including Chinook Therapeutics, where she … Continued

Sandy Lewis is the Senior Vice President of Biometrics and Clinical Strategy at Jade Biosciences, bringing over 25 years of experience in biostatistics, clinical trial design, and global regulatory submissions. Most recently, she was Vice President of Biometrics at Chinook Therapeutics, where she built a high performing team and led biometrics strategy and clinical development. … Continued

Amy Sullivan is the Senior Vice President of Development Operations at Jade Biosciences. A veteran drug development leader with nearly three decades of experience, Amy has a proven track record of delivering successful clinical programs from early development through post-approval.   Before joining Jade Biosciences, Amy served as the Senior Vice President of Development Operations at … Continued

Lori Stewart is the Senior Vice President of People at Jade Biosciences, bringing more than 25 years of experience in human resources leadership across biotechnology, financial services, and technology industries. She specializes in people strategy, organizational development, talent management, and fostering inclusive workplace cultures. Before joining Jade Biosciences, Lori served as SVP, People and Culture … Continued